Literature DB >> 20118961

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.

Yihai Cao1.   

Abstract

Current pharmacotherapeutic options for treating obesity and related metabolic disorders remain limited and ineffective. Emerging evidence shows that modulators of angiogenesis affect the expansion and metabolism of fat mass by regulating the growth and remodelling of the adipose tissue vasculature. Pharmacological manipulation of adipose tissue neovascularization by angiogenic stimulators and inhibitors might therefore offer a novel therapeutic option for the treatment of obesity and related metabolic disorders. This Perspective discusses recent progress in understanding the molecular mechanisms that control adipose tissue angiogenesis and in defining potential new vascular targets and approaches for the treatment of this group of diseases.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20118961     DOI： 10.1038/nrd3055

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  135 in total

1.  Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee.

Authors:  D Ladin
Journal:  Plast Reconstr Surg       Date:  2000-03       Impact factor: 4.730

2.  You are what you secrete.

Authors:  A R Saltiel
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

Review 3.  Potential use of stem cells from bone marrow to repair the extracellular matrix and the central nervous system.

Authors:  D J Prockop; S A Azizi; D Colter; C Digirolamo; G Kopen; D G Phinney
Journal:  Biochem Soc Trans       Date:  2000       Impact factor: 5.407

Review 4.  Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers.

Authors:  David L Steed
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

5.  Matrix metalloproteinase inhibition impairs adipose tissue development in mice.

Authors:  H R Lijnen; E Maquoi; L B Hansen; B Van Hoef; L Frederix; D Collen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

6.  Why we should put clothes on mice.

Authors:  Irfan J Lodhi; Clay F Semenkovich
Journal:  Cell Metab       Date:  2009-02       Impact factor: 27.287

7.  Adipose tissue mass can be regulated through the vasculature.

Authors:  Maria A Rupnick; Dipak Panigrahy; Chen-Yu Zhang; Susan M Dallabrida; Bradford B Lowell; Robert Langer; M Judah Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

8.  Effects of surface-modified scaffolds on the growth and differentiation of mouse adipose-derived stromal cells.

Authors:  Jing Lin; Merry L Lindsey; Beili Zhu; C Mauli Agrawal; Steven R Bailey
Journal:  J Tissue Eng Regen Med       Date:  2007 May-Jun       Impact factor: 3.963

Review 9.  Endothelial dysfunction in insulin resistance and type 2 diabetes.

Authors:  P-A Jansson
Journal:  J Intern Med       Date:  2007-08       Impact factor: 8.989

10.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

Authors:  Ebba Bråkenhielm; Niina Veitonmäki; Renhai Cao; Shinji Kihara; Yuji Matsuzawa; Boris Zhivotovsky; Tohru Funahashi; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205
View more
  146 in total

Review 1.  Adipose tissue remodeling and obesity.

Authors:  Kai Sun; Christine M Kusminski; Philipp E Scherer
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion.

Authors:  Alexis Cutchins; Daniel B Harmon; Jennifer L Kirby; Amanda C Doran; Stephanie N Oldham; Marcus Skaflen; Alexander L Klibanov; Nahum Meller; Susanna R Keller; James Garmey; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

Review 3.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

4.  Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice.

Authors:  Fen Xu; David Burk; Zhanguo Gao; Jun Yin; Xia Zhang; Jianping Weng; Jianping Ye
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

5.  18F-fluorobenzyl triphenyl phosphonium: a noninvasive sensor of brown adipose tissue thermogenesis.

Authors:  Igal Madar; Takuro Isoda; Paige Finley; James Angle; Richard Wahl
Journal:  J Nucl Med       Date:  2011-04-15       Impact factor: 10.057

6.  Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis.

Authors:  Marek Wagner; Rolf Bjerkvig; Helge Wiig; Juan M Melero-Martin; Ruei-Zeng Lin; Michael Klagsbrun; Andrew C Dudley
Journal:  Angiogenesis       Date:  2012-05-22       Impact factor: 9.596

Review 7.  Morphological and inflammatory changes in visceral adipose tissue during obesity.

Authors:  Xavier S Revelo; Helen Luck; Shawn Winer; Daniel A Winer
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

8.  Human adipose tissue contains erythroid progenitors expressing fetal hemoglobin.

Authors:  Amparo Navarro; Francisco Carbonell-Uberos; Severiano Marín; María Dolores Miñana
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

9.  Effects of tunable, 3D-bioprinted hydrogels on human brown adipocyte behavior and metabolic function.

Authors:  Mitchell Kuss; Jiyoung Kim; Dianjun Qi; Shaohua Wu; Yuguo Lei; Soonkyu Chung; Bin Duan
Journal:  Acta Biomater       Date:  2018-03-16       Impact factor: 8.947

10.  Tissue engineering chamber promotes adipose tissue regeneration in adipose tissue engineering models through induced aseptic inflammation.

Authors:  Zhangsong Peng; Ziqing Dong; Qiang Chang; Weiqing Zhan; Zhaowei Zeng; Shengchang Zhang; Feng Lu
Journal:  Tissue Eng Part C Methods       Date:  2014-03-31       Impact factor: 3.056
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.